Clinical Trials Logo

Clinical Trial Summary

To asses the effect of the probiotic and influenza vaccination alone and combination on enhancing immune response to influenza-like illness (ILI) and reducing ILI incidence in the elderly


Clinical Trial Description

To see percetange of subjects seroconvertion and seroprotection before and after intervention in the elderly (>60 years), and monitored for 6 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03695432
Study type Interventional
Source Indonesia University
Contact
Status Completed
Phase Phase 4
Start date October 2014
Completion date July 2016

See also
  Status Clinical Trial Phase
Completed NCT02302924 - Evaluation of Psychometric Testing Properties of Severity Symptom Grading Scale of Influenza Infection: Flu-PRO Stage III
Completed NCT00981513 - Direct and Indirect Benefits of Influenza Vaccination in Schools and Households Phase 4
Completed NCT03274310 - FluSAFE: Flu SMS Alerts to Freeze Exposure N/A
Active, not recruiting NCT03734237 - A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD Phase 4
Completed NCT04646980 - Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses N/A
Completed NCT03599739 - Adjuvanted Influenza Vaccination Year 2 Follow-On Survey
Completed NCT02979730 - Impact of Rapid Flu Testing in BMC ED N/A
Completed NCT03454009 - Kent State University / Price Chopper Employee Wellness Study N/A
Active, not recruiting NCT01687816 - Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting N/A
Completed NCT00448773 - REDucing Influenza Among University Students, University of California at Berkeley Phase 4
Completed NCT03656198 - Non-specific Effects of Rabies Vaccine Phase 4
Completed NCT02882100 - Adjuvanted Influenza Vaccination in U.S. Nursing Homes Phase 4
Completed NCT01418287 - Characterization of Influenza-like Illness in Mexico N/A